Wednesday - February 26, 2020
FDA, FTC Warn Company Marketing Unapproved Cannabidiol Products With Claims to Treat Teething Pain in Infants
October 22, 2019
WASHINGTON, Oct. 22 -- The U.S. Department of Health and Human Services' Food and Drug Administration issued the following news release:

* * *

- FDA is also working quickly to evaluate regulatory policies related to cannabis and cannabis-derived ingredients like CBD

* * *

Today, the U.S. Food and Drug Administration and the Federal Trade Commission posted a joint warning letter to Rooted Apothecary LLC, of Naples, Florida, for illegally selling . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products